Craft

Zimmer Biomet

Stock Price

$103.9

2024-10-29

Market Capitalization

$21.2 B

2024-10-29

Revenue

$7.7 B

FY, 2024

Zimmer Biomet Summary

Company Summary

Overview
Zimmer Biomet Holdings is a medical technology company that develops implants and digital technologies. It offers ROSA robotics, a Persona IQ smart implant that captures key kinematic data metrics, mymobility digital care management platform that delivers data and patient-reported feedback, Keel Tibia for cementless knee replacement, etc. The company caters to the robotics, biologics, pharmaceuticals, and other sectors.
Type
Public
Status
Active
Founded
1927
HQ
Warsaw, IN, US | view all locations
Website
https://www.zimmerbiomet.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Ivan Tornos

    Ivan Tornos, President and Chief Executive Officer

  • Angela Main

    Angela Main, Senior Vice President, Global Chief Compliance Officer and Associate General Counsel, Asia Pacific

  • Rachel Ellingson

    Rachel Ellingson, Senior Vice President and Chief Strategy Officer

  • Zeeshan Tariq

    Zeeshan Tariq, Senior Vice President and Chief Information Officer

Operating MetricsView all

Countries (Facilities)

45

FY, 2022

Manufacturing Facilities

25
28.6%

FY, 2022

Facilities

280
17.6%

FY, 2022

LocationsView all

52 locations detected

  • Warsaw, IN HQ

    United States

    1800 W Center St

  • Dover, OH

    United States

    200 W Ohio Ave

  • Miami, FL

    United States

    6303 Blue Lagoon Dr

  • Warsaw, IN

    United States

    P.O. Box 708

  • Belrose, NSW

    Australia

    3/12 Narabang Way

  • Wien, Wien

    Austria

    Lehrbachgasse 13

and 46 others

Zimmer Biomet Financials

Summary Financials

Revenue (FY, 2024)
$7.7B
Gross profit (FY, 2024)
$5.5B
Net income (FY, 2024)
$905.3M
Cash (FY, 2024)
$525.5M
EBIT (FY, 2024)
$1.3B
Enterprise value
$26.8B

Footer menu